Downregulation and/or Release of NKG2D Ligands as Immune Evasion Strategy of Human Neuroblastoma
Open Access
- 1 September 2004
- Vol. 6 (5) , 558-568
- https://doi.org/10.1593/neo.04316
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Roles of the NKG2D immunoreceptor and its ligandsNature Reviews Immunology, 2003
- Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemiaBlood, 2003
- Human Cytomegalovirus Glycoprotein UL16 Causes Intracellular Sequestration of NKG2D Ligands, Protecting Against Natural Killer Cell CytotoxicityThe Journal of Experimental Medicine, 2003
- In search of the ‘missing self’: MHC molecules and NK cell recognitionPublished by Elsevier ,2003
- Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activationNature, 2002
- Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated CytolysisAnnual Review of Immunology, 2001
- ULBPs, Novel MHC Class I–Related Molecules, Bind to CMV Glycoprotein UL16 and Stimulate NK Cytotoxicity through the NKG2D ReceptorPublished by Elsevier ,2001
- Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICAScience, 1999
- RECEPTORS FOR HLA CLASS-I MOLECULES IN HUMAN NATURAL KILLER CELLSAnnual Review of Immunology, 1996
- Uncoordinate induction and differential regulation of hla class‐I and class‐II expression by γ‐interferon in differentiating human neuroblastoma cellsInternational Journal of Cancer, 1993